Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             96 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Accounting for Interim Safety Monitoring of an Adverse Event Upon Termination of a Clinical Trial Dallas, Michael J.
2008
4 p. 631-638
artikel
2 A Class of Repeated Measures Concordance Correlation Coefficients King, Tonya S.
2007
4 p. 653-672
artikel
3 A comparison of the random-effects pattern mixture model with last-observation-carried-forward(locf) analysis in longitudinal clinical trials with dropouts Siddiqui, Ohidul
1998
4 p. 545-563
artikel
4 Adaptive survival trials Rosenberger, William F.
1997
4 p. 617-624
artikel
5 A global model to define the behavior of partial agonists (bell-shaped dose-response inducers) in pharmacological evaluation of activity in the presence of the full agonist Ghosh, Krishnendu
1998
4 p. 645-665
artikel
6 Agreement Between Methods of Measurement with Multiple Observations Per Individual Bland, J. Martin
2007
4 p. 571-582
artikel
7 A logistic dose-ranging method for phase i clinical investigations trials Murphy, James R.
1997
4 p. 635-647
artikel
8 A Method for Constructing and Estimating the RR-Memory of the QT-Interval and Its Inclusion in a Multivariate Biomarker for Torsades de Pointes Risk Trost, Donald C.
2008
4 p. 773-796
artikel
9 Analysis and design of repeated measures in clinical trials using summary statistics Ogenstad, Stephan
1997
4 p. 593-604
artikel
10 Analysis of 24-hour blood pressure data Rodda, B.
1996
4 p. 495-513
artikel
11 Analytical Expressions for Combining Population Pharmacokinetic Parameters from Different Studies Dokoumetzidis, Aristides
2008
4 p. 662-676
artikel
12 An example of using mixed models and proc mixed for longitudinal data Wolfinger, Russell D.
1997
4 p. 481-500
artikel
13 A note on the sample size determination in two-period repeated measurements crossover design with application to clinical trials Yue, Lilly Q.
1998
4 p. 577-584
artikel
14 A note on the small sample behavior of logistic regression in a bioassay setting Nottingham, Quinton J.
1998
4 p. 565-576
artikel
15 An Overview on Assessing Agreement with Continuous Measurements Barnhart, Huiman X.
2007
4 p. 529-569
artikel
16 A power study of a sequential method of p-value adjustment for correlated continuous endpoints Arani, Ramin B.
1998
4 p. 585-598
artikel
17 Applied Mixed Models in Medicine, Second Edition, by H. Brown and R. Prescott Shults, Justine
2007
4 p. 769-773
artikel
18 A reviewer's perspective on multiple endpoint issues in clinical trials Huque, M. F.
1997
4 p. 545-564
artikel
19 A Review of: “Applied Regression Analysis and Other Multivariable Methods, 4th ed., by D. G. Kleinbaum, L. L. Kupper, A. Nizam, and K. E. Muller” Hayden, Robert W.
2008
4 p. 797-798
artikel
20 A Review of: “Design and Analysis of DNA Microarray Investigations” Hardin, Johanna
2005
4 p. 747-749
artikel
21 A Review of: “Design of Studies for Medical Research” Noursalehi, Mojtaba
2006
4 p. 573-575
artikel
22 A Review of: “Interpreting and Reporting Clinical Trials: A Guide to the CONSORT Statement and the Principles of Randomised Controlled Trials, by A. Keech, V. Gebski, and R. Pike (eds.)” Simon, Steve
2008
4 p. 802-804
artikel
23 A Review of: “Mixed Models: Theory and Applications” Hurtado, Gerardo I.
2005
4 p. 751-752
artikel
24 A Review of: “New Drug Development: Design, Methodology, and Analysis, by J. R. Turner” McCague, Kevin
2008
4 p. 799-801
artikel
25 A review of nonparametric tests for :changepoint problems, with application to a recombinant drug therapy clinical trial Koziol, James A.
1996
4 p. 425-441
artikel
26 A Review of: “Statistics: A Guide to the Unknown” Hayden, Robert W.
2006
4 p. 577-578
artikel
27 A Safety Monitoring Procedure for a Clinical Drug Development Program, with Application to the Assessment of a Novel COX-2 Inhibitor Bolland, Kim
2008
4 p. 737-749
artikel
28 Assessing Individual Agreement Barnhart, Huiman X.
2007
4 p. 697-719
artikel
29 Assessing Observer Agreement in Studies Involving Replicated Binary Observations Haber, Michael
2007
4 p. 757-766
artikel
30 A Tolerance Interval Approach for Assessment of Agreement with Left Censored Data Choudhary, Pankaj K.
2007
4 p. 583-594
artikel
31 A Unified Approach for Assessing Agreement for Continuous and Categorical Data Lin, Lawrence
2007
4 p. 629-652
artikel
32 Author Index to Volume 13 2003
4 p. 807-809
artikel
33 BIOPHARMACEUTICAL STATISTICS IN A PHARMACEUTICAL REGULATED ENVIRONMENT: PAST, PRESENT, AND FUTURE Segreti, Anthony C.
2002
4 p. 347-372
artikel
34 Book Review Mietlowski, William
2004
4 p. 1099-1101
artikel
35 Book Review Pennello, Gene
2004
4 p. 1103-1106
artikel
36 Book Review Holmgren, Eric
2004
4 p. 1107-1108
artikel
37 Clinical trial designs—made to order Andersen, John S.
1996
4 p. 515-522
artikel
38 Clinical Trials Simulation: A Statistical Approach Westfall, Peter H.
2008
4 p. 611-630
artikel
39 Commentary on “Accounting for Interim Safety Monitoring of an Adverse Event Upon Termination of a Clinical Trial” Tsong, Yi
2008
4 p. 639-640
artikel
40 Commentary on “Accounting for the Interim Safety Monitoring of an Adverse Event Upon Termination of a Clinical Trial” Liu, Jen-pei
2008
4 p. 641-643
artikel
41 Comparison of Concordance Correlation Coefficient and Coefficient of Individual Agreement in Assessing Agreement Barnhart, Huiman X.
2007
4 p. 721-738
artikel
42 Comparison of Concordance Correlation Coefficient Estimating Approaches with Skewed Data Carrasco, Josep L.
2007
4 p. 673-684
artikel
43 Compound Optimal Design Criteria for Nonlinear Models McGree, J. M.
2008
4 p. 646-661
artikel
44 Conceptual and statistical issues in the validation of analytic dilution assays for pharmaceutical applications Smith, Wendell C.
1998
4 p. 509-532
artikel
45 Crossover trials with a cumulative response Walter, Stephen D.
1997
4 p. 649-666
artikel
46 Cumulative Statistical Power for Hierarchical Comparisons to Evaluate Two Combination Drug Doses Matsukura, Tomoharu
2008
4 p. 750-772
artikel
47 Design of Vaccine Equivalence/Non-Inferiority Trials with Correlated Multiple Binomial Endpoints Kong, L.
2006
4 p. 555-572
artikel
48 Editorial board 1998
4 p. 1
artikel
49 Editorial board 1996
4 p. 1
artikel
50 Editorial board 1997
4 p. 1
artikel
51 Effect of delayed observations on bayesian decisions for binary data Williamson, Patricia Pepple
1998
4 p. 599-617
artikel
52 Estimating Reliability and Generalizability from Hierarchical Biomedical Data Molenberghs, Geert
2007
4 p. 595-627
artikel
53 Estimating Vaccine Efficacy from Outbreak Size Household Data in the Presence of Heterogeneous Transmission Probabilities Davis, X. M.
2006
4 p. 499-516
artikel
54 Etrank:a ranking procedure for handling missing data in clinical trials:application to venlafaxine extended-release depression clinical trial Entsuah, Richard
1996
4 p. 457-475
artikel
55 Evaluation of the Indirect Effects of a Pneumococcal Vaccine in a Community-Randomized Study Moulton, L. H.
2006
4 p. 453-462
artikel
56 Evolution of the canda at roche Rutman, Olga
1997
4 p. 605-615
artikel
57 Generalizability in NonGaussian Longitudinal Clinical Trial Data Based on Generalized Linear Mixed Models Vangeneugden, Tony
2008
4 p. 691-712
artikel
58 Guest Editorial - Preventive Vaccines Horne, A. D.
2006
4 p. 399-402
artikel
59 Guest Editors' Note 2005
4 p. 535
artikel
60 Guest Editor's Note for the Special Issue on Assessing Agreement Barnhart, Huiman X.
2007
4 p. 525-527
artikel
61 Industry, Government, and Academic Panel Discussion on Multiple Comparisons in a “Real” Phase Three Clinical Trial Bauer, Peter
2003
4 p. 691-701
artikel
62 Inference and Sample Size Calculation in the Fit Assessment of Filtering Facepiece Respirators Zhang, Zhiwei
2008
4 p. 713-723
artikel
63 Interim analyses and early termination of clinical trials 1997
4 p. 533-543
artikel
64 Introduction Westfall, Peter H.
2003
4 p. 7-10
artikel
65 In vitro-in vivo relationships for oral extended-release drug products Mauger, David T.
1997
4 p. 565-578
artikel
66 JBS Referee List 2003-2004 Volume 14, Number 1-4 2004
4 p. 1-2
artikel
67 Joint Inferences on Vaccine Efficacy Against Infection and Disease with Application to the First HIV Vaccine Efficacy Trial Cai, T.
2006
4 p. 517-538
artikel
68 Longitudinal analyses for magnetic resonance imaging outcomes in multiple sclerosis clinical trials D'yachkova, Yulia
1997
4 p. 501-531
artikel
69 Meta-analysis of clinical trials: a consumer's guide Geller, Nancy L.
1996
4 p. 377-394
artikel
70 Multiple-objective optimal designs Huang, Yu-Chung
1998
4 p. 635-643
artikel
71 Multistage Designs for Vaccine Safety Studies Dragalin, V.
2006
4 p. 539-553
artikel
72 On Methods to Utilize HIV-RNA Data Measured by Two Different PCR Assays Joshua Chen, Y. H.
2008
4 p. 724-736
artikel
73 On Statistical Evaluation of the Linearity in Assay Validation Hsieh, Eric
2008
4 p. 677-690
artikel
74 On the Use of Zero-Inflated and Hurdle Models for Modeling Vaccine Adverse Event Count Data Rose, C. E.
2006
4 p. 463-481
artikel
75 Overview of Vaccine Field Studies: Types of Effects and Designs Halloran, M. E.
2006
4 p. 415-427
artikel
76 Patterns of Immune Response to a Vaccine or Virus as Measured by Intracellular Cytokine Staining in Flow Cytometry: Hypothesis Generation and Comparison of Groups Nason, M.
2006
4 p. 483-498
artikel
77 PROGRESS REPORT ON THE GUIDANCE FOR INDUSTRY FOR STATISTICAL ASPECTS OF THE DESIGN, ANALYSIS, AND INTERPRETATION OF CHRONIC RODENT CARCINOGENICITY STUDIES OF PHARMACEUTICALS Lin, Karl K.
2000
4 p. 481-501
artikel
78 Referees to Volume 13 2003
4 p. 803-805
artikel
79 Regression Models for Method Comparison Data Dunn, Graham
2007
4 p. 739-756
artikel
80 Relationship of whole-blood FK506 concentrations to rejection and toxicity in liver and kidney transplants Hedayat, Samad
1996
4 p. 411-424
artikel
81 Resampling Dependent Concordance Correlation Coefficients Williamson, John M.
2007
4 p. 685-696
artikel
82 Response to Commentary 2008
4 p. 644-645
artikel
83 Statistical Analysis of Influenza Vaccine Lot Consistency Studies Nauta, J.
2006
4 p. 443-452
artikel
84 Statistical applications for in vitro diagnostic tests and other medical device clinical trials Lao, Chang S.
1997
4 p. 579-591
artikel
85 Statistical Considerations for NonInferiority/Equivalence Trials in Vaccine Development Wang, W. W. B.
2006
4 p. 429-441
artikel
86 Statistical strategies for event rate comparisons in dental studies Davies, Glenn M.
1997
4 p. 625-634
artikel
87 Study Design and Statistical Analysis: A Practical Guide for Clinicians, by M. H. Katz Hayden, Robert W.
2007
4 p. 767-768
artikel
88 Subject Index to Volume 13 2003
4 p. 811-816
artikel
89 Survival and projection analyses of the effect of radiation on beagle dogs Lao, Chang S.
1998
4 p. 619-633
artikel
90 The cardinal features of cognitive and noncognitive dysfunction and the differential efficacy of tacrine in alzheimer's disease Patients Talwalker, Sheela
1996
4 p. 443-456
artikel
91 The conditional binomial test revisited for clinical trials Lei, Xingye
1998
4 p. 533-543
artikel
92 The use of generalized tests in medical research Ogenstad, Stephan
1998
4 p. 497-508
artikel
93 The use of survival analysis techniques in evaluating the effect of long-term tacrine (cognex®) treatment on nursing home placement and mortality in patients with Smith, Fraser
1996
4 p. 395-409
artikel
94 Uniform matrix stability study designs Murphy, John R.
1996
4 p. 477-494
artikel
95 Using Adaptive Tests for the Analysis of Repeated Measurements O'Gorman, T. W.
2008
4 p. 595-610
artikel
96 Vaccine Clinical Trials - A Statistical Primer Mehrotra, D. V.
2006
4 p. 403-414
artikel
                             96 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland